Showing posts with label Clinical Nutrition Market. Show all posts
Showing posts with label Clinical Nutrition Market. Show all posts

Sunday, 6 June 2021

Oral Segment to Dominate the United States Clinical Nutrition Market | TechSci Research

Increasing prevalence of metabolic disorders and high healthcare expenditure is expected to drive the demand for United States clinical nutrition market for the forecast period.

United States Clinical Nutrition Market - TechSci Research

According to TechSci Research report, United States Clinical Nutrition Market By Nutrition Type (Enteral Nutrition v/s Parental Nutrition) By Route of Administration (Oral v/s Intravenous) By Substrate (Energy, Carbohydrates, Lipids, Proteins & Amino Acids, Water & Electrolyte, Dietary fiber, Antioxidants) By Application (Metabolic Disorders, Eating Disorders, Stages of Development and Recovery, Others) By End User (Infant & Child, Adults, Geriatrics) By Company, By Region, Forecast & Opportunities, 2026”, United States clinical nutrition market is expected to witness significant growth for the next five years. Clinical nutrition is a kind of pharmaceutical product which is taken to keep the patient healthy. It aids in improving the metabolic system of the body by providing supply of supplementary vitamins and minerals, among others. Increase in the number of birth rates and premature birth require the use of clinical nutrition.

The COVID-19 outbreak across the world which has been declared as pandemic by World Health Organization has affected countries adversely. Leading authorities in United States imposed lockdown restrictions and released a set of precautionary measures to contain the spread of novel coronavirus. Coronavirus affected patients started suffering from shortness of breath along with coughing and sneezing. United States authorities increased the capacity of hospitals as a greater number of patients were getting affected daily and getting admitted into the hospital facilities. Demand for immunity booster alternatives as a preventive measure from being affected by coronavirus witnessed surge in the growth. Old age people and children after getting infected with coronavirus suffers lack of appetite along with diarrhea, anosmia dysgeusia both of which can increase the risk of malnutrition. Malnutrition can lead to lower defense levels of the body and loss of muscles which can affect the health of the patient adversely. Therefore, the clinical nutrition market is expected to be positively impacted with the onset of coronavirus pandemic.

However, lack of awareness about the benefits of clinical nutrition may create hindrance in the clinical nutrition market growth.

Browse XX Figures spread through XX Pages and an in-depth TOC on "United States Clinical Nutrition Market”.

https://www.techsciresearch.com/report/united-states-clinical-nutrition-market/7488.html

United States clinical nutrition market is segmented into nutrition type, route of administration, substrate, application, end user, regional distribution, and company. Based on application, market is further divided into metabolic disorders, eating disorders, stages of development and recovery and others. The metabolic disorders segment is expected to dominate the clinical nutrition marker for the forecast period, 2022-2026. People getting infected by coronavirus require the dosage of clinical nutrition to prevent the cases of malnutrition. Lack of some essential vitamins and minerals gives rise to a number of diseases and rise in awareness among people is contributing to raise the growth of the clinical nutrition market in United States. Based on end user, market is majorly categorized into infant & child, adults, and geriatrics. The infant & child segment is anticipated to hold major market share for the next five years. Rise in number of premature births and malnourished babies is driving the growth of the market. Introduction of infant nutritional products by the major market players and organization of camps and programs to raise the awareness about the importance of clinical nutrition is fostering the demand for clinical nutrition in United States.

Nestle USA, Danone USA, Abbott Nutrition Ltd., Fresenius Kabi USA, Inc., Baxter International, Inc., B Braun USA, Conmed Corporation, Vesco Medical LLC, Pfizer Inc., Otsuka America Pharmaceutical Inc. are the leading players operating in United States clinical nutrition market. Manufacturers are increasingly focusing on research and development process to fuel higher growth in the market. To meet evolving customer demand with respect to better efficiency and durability, several clinical nutrition manufacturers are coming up with their technologically advanced offerings.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7488

Customers can also request for 10% free customization on this report.

“Increase in occurrence of cancer and diabetes along with rising old age population is fueling the need for adoption of clinical nutrition in regular diets suffering from chronic diseases are deprived from the presence of few essential nutrition. Adoption of unhealthy eating habits and sedentary lifestyle is contributing to the rise in number of obese populations in United States. Manufacturers are selling clinical nutrition products through online platforms along with offering of lucrative discounts to widen the reach of products and sales of clinical products which is further expected to propel the clinical nutrition market growth until 2026” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“United States Clinical Nutrition Market By Nutrition Type (Enteral Nutrition v/s Parental Nutrition) By Route of Administration (Oral v/s Intravenous) By Substrate (Energy, Carbohydrates, Lipids, Proteins & Amino Acids, Water & Electrolyte, Dietary fiber, Antioxidants) By Application (Metabolic Disorders, Eating Disorders, Stages of Development and Recovery, Others) By End User (Infant & Child, Adults, Geriatrics) By Company, By Region, Forecast & Opportunities, 2026” has evaluated the future growth potential of United States clinical nutrition market and provided statistics & information on market size, shares, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the of United States clinical nutrition market.

Browse Related Reports:

Global Clinical Nutrition Market By Route of Administration (Oral, Intravenous), By Nutrition Type (Enteral Nutrition, Parental Nutrition), By Application (Metabolic Disorders, Eating Disorders, Stages of Development and Recovery, Others), By End User (Infant & Child, Adults, Geriatrics), By Substrates (Energy, Carbohydrates, Lipids, Proteins & amino acids, Water & electrolyte, Dietary fiber, Antioxidants), By Region, Competition, Forecast & Opportunities, 2025

https://www.techsciresearch.com/report/clinical-nutrition-market/4664.html

Global Sports Nutrition Market By Product Type (Sports Food, Sports Drinks and Sports Supplements), By Distribution Channel (Pharmacies/Drug Stores, Supermarket/Hypermarket, Direct Selling, Departmental/Retail Stores, Internet/Online and Others), By Company, By Region, Forecast & Opportunities, 2026

https://www.techsciresearch.com/report/sports-nutrition-market/4802.html

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: sales@techsciresearch.com

Website: https://www.techsciresearch.com/

For More Market Research Blogs Visit: https://techsciblog.com/

Monday, 21 December 2020

Clinical Nutrition Market to be valued USD 82.23 Billion by 2025 – TechSci Research

Rising prevalence of chronic diseases and government initiatives to increase health awareness and minimize malnourishment are expected to drive Global Clinical Nutrition Market through 2025.

Clinical Nutrition Market - TechSci Research
According to TechSci Research report, Global Clinical Nutrition Market By Route of Administration (Oral, Intravenous), By Nutrition Type (Enteral Nutrition, Parental Nutrition), By Application (Metabolic Disorders, Eating Disorders, Stages of Development and Recovery, Others), By End User (Infant & Child, Adults, Geriatrics), By Substrates (Energy, Carbohydrates, Lipids, Proteins & amino acids, Water & electrolyte, Dietary fiber, Antioxidants), By Region, Competition, Forecast & Opportunities, 2025, the Global Clinical Nutrition market was valued at USD54.85 billion in 2019 is estimated to grow at an impressive rate of 7.36% during the forecast period. Factors contributing to the market growth include growing geriatric population and advancement in healthcare infrastructure in developing economies. Increasing awareness pertaining to health and fitness among people, expanding global population are also contributing to the global clinical nutrition market growth. Rising personal disposable income, and surge in cases of premature birth are some of the key factors behind the growth of clinical nutrition market, globally. Increasing research and development activities for nutrition advancements expansion of key players through diverse product launches, merger & acquisition and strategic collaboration are further expected to fuel the Global Clinical Nutrition market through 2025. Moreover, with rising prevalence of metabolic diseases, the number of patients opting for the diagnosis of metabolic disorders has also increased over the years, thereby fueling the market growth. Furthermore, various governments and international organizations are taking initiatives to improve the health rate and thus, increasing investments in healthcare sector and funding from international and national organizations is further propelling the growth of the market across the globe.

However, lack of awareness about clinical nutrients and high cost or side effects of nutritional products might hamper the growth of the market. Decrease in fertility rates and prevalence of several diseases among this population is stressing on the need of global clinical nutrition market. Additionally, stringent regulatory scenario and lack of awareness related to clinical nutrition might hamper the growth of clinical nutrition market.

Clinical Nutrition Market - TechSci Research
Browse 199 Figures spread through 185 Pages and an in-depth TOC on " Global Clinical Nutrition Market"

https://www.techsciresearch.com/report/clinical-nutrition-market/4664.html

The global clinical nutrition market is segmented based on route of administration, nutrition type, application, end users, substrates, company and region. Based on route of administration, the market is further segmented into oral and intravenous. Among them, the oral endoscopic route of administration occupied the lion’s share in the market in 2019 as it is preferred by majority of people since, it involves lesser complexities and low cost. Based on nutrition type, the market is segmented into enteral nutrition and parental nutrition. The enteral nutrition is further divided into oral nutrition supplements and tube feeding. The parental nutrition segment is divided into supplemental parenteral nutrition, total parenteral nutrition, all-in-one system and multiple bottle system. Globally, the enteral nutrition is anticipated to hold dominant market share until 2025 in terms of revenue owing to their ease of administration and wide availability of products like powders, capsules, soft gels, and liquids.

Nestle S.A., Danone S.A., Abbott Nutrition, Fresenius SE & Co. KGaA, Otsuka Holdings Co. Ltd., Baxter International Inc., B Braun Melsungen AG, Meiji Holding Co. Ltd., BASF SE, CONMED Corporation, Lonza Group AG, Vesco Medical LLC, Perrigo Company Plc, Pfizer Inc., Reckitt Benckiser Group Plc., and others are some of the leading players operating in global clinical nutrition market.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4664

Customers can also request for 10% free customization on this report.

“Major market players in clinical nutrition are expanding their businesses through mergers & acquisitions and strategic collaborations. The usage of nutritional products in home care sector has created more growth opportunities for companies. Over the last decade, more than 50 per cent of market share was held by infant nutrition market segment. Hence this segment has huge growth potential for manufacturers. Therefore, the companies need to focus on launching innovative and newer clinical nutrition products to maintain a strong hold in the ever-evolving global market”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

Global Clinical Nutrition Market By Route of Administration (Oral, Intravenous), By Nutrition Type (Enteral Nutrition, Parental Nutrition), By Application (Metabolic Disorders, Eating Disorders, Stages of Development and Recovery, Others), By End User (Infant & Child, Adults, Geriatrics), By Substrates (Energy, Carbohydrates, Lipids, Proteins & amino acids, Water & electrolyte, Dietary fiber, Antioxidants), By Region, Competition, Forecast & Opportunities, 2025” has evaluated the future growth potential of global clinical nutrition market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global clinical nutrition market.

Browse Related Reports

Europe Biosimilar Insulin Glargine & Lispro Market By End User (Type 1 Diabetes and Type 2 Diabetes),By Country (Germany, United Kingdom, France, Italy, Spain, Russia, Turkey, Poland, The Netherlands, Austria & Rest of Europe), Competition, Forecast & Opportunities, 2024

https://www.techsciresearch.com/report/europe-biosimilar-insulin-glargine-and-lispro-market/4278.html

Asia Pacific Biosimilar Insulin Glargine & Lispro Market By End User (Type 1 Diabetes and Type 2 Diabetes), By Country (Japan, China, India, South Korea, Bangladesh, Pakistan), Competition, Forecast & Opportunities, 2024

https://www.techsciresearch.com/report/asia-pacific-biosimilar-insulin-glargine-and-lispro-market/4282.html

About TechSci Research

TechSci Research is a leading global market research firm publishing premium market research reports. Serving 700 global clients with more than 600 premium market research studies, TechSci Research is serving clients across 11 different industrial verticals. TechSci Research specializes in research-based consulting assignments in high growth and emerging markets, leading technologies and niche applications. Our workforce of more than 100 fulltime Analysts and Consultants employing innovative research solutions and tracking global and country specific high growth markets helps TechSci clients to lead rather than follow market trends.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: sales@techsciresearch.com